What is PriMed Pharmaceuticals?
PriMed Pharmaceuticals, a NABP Accredited drug distributor based in New Jersey, operates as a price-driven alternative for generic drug procurement, serving independent community pharmacies. The company distinguishes itself by offering high-quality generic pharmaceuticals that deliver consistent savings, thereby supporting the financial health of its pharmacy clients. PriMed's commitment extends to providing personalized customer service and expert support, ensuring clients remain informed about pricing dynamics and potential drug shortages, facilitating dependable and efficient supply chain solutions.
How much funding has PriMed Pharmaceuticals raised?
PriMed Pharmaceuticals has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for PriMed Pharmaceuticals?
The recent major strategic investment signals a pivotal moment for PriMed Pharmaceuticals, indicating a strong market confidence in its business model and future growth potential. As a company focused on providing cost-effective generic drug solutions to community pharmacies, this capital infusion is likely to fuel initiatives aimed at expanding its distribution network, enhancing its technological infrastructure for procurement and logistics, and potentially broadening its product portfolio. The late-stage funding context suggests PriMed is poised for significant scaling, possibly through strategic partnerships or acquisitions, to further solidify its competitive advantage in the pharmaceutical supply chain.
See full PriMed Pharmaceuticals company page
